IBSA PHARMA INC 2023-03-01 Health serious FDA
Health · FDA · Recall #FDA-D-0344-2023
TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5… Recall
Issued March 1, 2023 · IBSA PHARMA INC
In March 2023, IBSA PHARMA INC recalled the TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Subpotent Drug
What you should do
- 1 Stop using TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact IBSA PHARMA INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- IBSA PHARMA INC
- Category
- Health
- Recall date
- March 1, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA.
- Recall number
- FDA-D-0344-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- IBSA PHARMA INC has 6 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.